BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8257352)

  • 1. Effect of temperature on the stability of avian influenza virus antigens under different storage conditions.
    Fatunmbi OO; Newman JA; Halvorson DA; Sivanandan V
    Avian Dis; 1993; 37(3):639-46. PubMed ID: 8257352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of inactivated influenza vaccines in market turkeys.
    Karunakaran D; Newman JA; Halvorson DA; Abraham A
    Avian Dis; 1987; 31(3):498-503. PubMed ID: 3118863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative serological evaluation of avian influenza vaccine in turkeys.
    Abraham A; Sivanandan V; Karunakaran D; Halvorson DA; Newman JA
    Avian Dis; 1988; 32(4):659-62. PubMed ID: 3060086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
    Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
    Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
    Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
    Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks.
    Middleton D; Bingham J; Selleck P; Lowther S; Gleeson L; Lehrbach P; Robinson S; Rodenberg J; Kumar M; Andrew M
    Virology; 2007 Mar; 359(1):66-71. PubMed ID: 17028058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus.
    Capua I; Terregino C; Cattoli G; Toffan A
    Avian Pathol; 2004 Apr; 33(2):158-63. PubMed ID: 15276982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of avian influenza virus (AIV) subtypes H5N2 and H7N1 in emus (Dromaius novaehollandiae) and rheas (Rhea americana): virus isolation and serologic findings.
    Panigrahy B; Senne DA; Pearson JE
    Avian Dis; 1995; 39(1):64-7. PubMed ID: 7794192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenicity of four avian influenza viruses for fowls, turkeys and ducks.
    Alexander DJ; Allan WH; Parsons DG; Parsons G
    Res Vet Sci; 1978 Mar; 24(2):242-7. PubMed ID: 653122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Veits J; Römer-Oberdörfer A; Helferich D; Durban M; Suezer Y; Sutter G; Mettenleiter TC
    Vaccine; 2008 Mar; 26(13):1688-96. PubMed ID: 18291561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of H7N1 vaccination on highly pathogenic avian influenza H7N7 virus transmission in turkeys.
    Bos ME; Nielen M; Koch G; Stegeman A; De Jong MC
    Vaccine; 2008 Nov; 26(50):6322-8. PubMed ID: 18822335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the Subcommittee on Avian Influenza to the Committee on Transmissible Diseases of Poultry.
    Proc Annu Meet U S Anim Health Assoc; 1973; (77):246-50. PubMed ID: 4620448
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza.
    Swayne DE; Beck JR; Perdue ML; Beard CW
    Avian Dis; 2001; 45(2):355-65. PubMed ID: 11417815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving heat stability of haemagglutinating antigens for avian influenza.
    Pizzuto MS; De Benedictis P; Maniero S; Toson M; Dundon WG; M'Baye Seck B; Capua I
    Biologicals; 2011 May; 39(3):149-51. PubMed ID: 21454090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
    Lee CW; Senne DA; Suarez DL
    Vaccine; 2004 Aug; 22(23-24):3175-81. PubMed ID: 15297071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of avian influenza virus in Texas.
    Glass SE; Naqi SA; Grumbles LC
    Avian Dis; 1981; 25(2):545-9. PubMed ID: 6789814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection.
    Kodihalli S; Sivanandan V; Nagaraja KV; Shaw D; Halvorson DA
    Vaccine; 1994 Nov; 12(15):1467-72. PubMed ID: 7887025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens.
    Sakabe S; Sakoda Y; Haraguchi Y; Isoda N; Soda K; Takakuwa H; Saijo K; Sawata A; Kume K; Hagiwara J; Tuchiya K; Lin Z; Sakamoto R; Imamura T; Sasaki T; Kokumai N; Kawaoka Y; Kida H
    Vaccine; 2008 Apr; 26(17):2127-34. PubMed ID: 18346824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.